Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.45 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.45 |
| ▸ | CA12 | O43570 | 1/20 | 0.42 |
| ▸ | CA1 | P00915 | 1/20 | 0.42 |
| ▸ | CA2 | P00918 | 1/20 | 0.42 |
| ▸ | CA9 | Q16790 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27811117 | 0.75 | CA12 (0.65) | CA12CA1CA2CA9 | |
| SCHEMBL27811234 | 0.75 | MAPT (0.44) | CA12CA1CA2CA9 | |
| SCHEMBL250115 | 0.75 | LMNA (0.40) | CA12CA1CA2CA9 | |
| SCHEMBL596066 | 0.74 | SMN1; SMN2 (0.53) | — | |
| SCHEMBL4754841 | 0.74 | KDM4E (0.50) | SMPD1 | |
| SCHEMBL27699443 | 0.71 | CNR1 (0.54) | SMPD1 | |
| SCHEMBL1739252 | 0.71 | ALPL (0.46) | CA12CA1CA2CA9 | |
| SCHEMBL28820586 | 0.70 | CNR1 (0.71) | — | |
| SCHEMBL3614239 | 0.69 | KDM4E (0.51) | — | |
| SCHEMBL3434182 | 0.69 | ALDH1A1 (0.48) | CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140264166-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2014-09-18 | — | — | US | disclosed |
| US-20130264519-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2013-10-10 | — | — | US | disclosed |
| US-8470052-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2013-06-25 | — | — | US | disclosed |
| EP-1926713-B1 | PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECH CORP (US) | 2013-04-10 | — | — | EP | disclosed |
| US-20120118109-A1 | PHENOXYPYRAZOLE COMPOSITION AND PROCESS FOR THE SOLVENT EXTRACTION OF METALS | CYTEC TECHNOLOGY CORP. (US) | 2012-05-17 | — | — | US | disclosed |
| US-8088810-B2 | Phenoxypyrazole composition and process for the solvent extraction of metals | CYTEC TECHNOLOGY CORP. (US) | 2012-01-03 | — | — | US | disclosed |
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | CYTEC TECHNOLOGY CORP. | 2008-12-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080312452-A1 | Phenoxypyrazole Composition and Process for the Solvent Extraction of Metals | PRMT9, CHD9, CYP2C9 | TLR8 1989/4885SMPD1 4868/4885CA12 1372/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.